"At Yale New Haven Health, we deliver extraordinary, compassionate care by working alongside providers and payers on innovative, cost-effective healthcare delivery models that improve care and value for patients - and enhance the health of our communities."

During the past decade, Yale New Haven Hospital, York Street Campus conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale New Haven Hospital, York Street Campus" #1 collaborator was "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "Department of Anesthesiology Faculty Development Fund" with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Yale New Haven Hospital, York Street Campus" are "Acute Interstitial Nephritis" (1 trials), "Acute Kidney Injury" (1 trials), "Chronic Pain" (1 trials), "Circadian Rhythm Disorders" (1 trials) and "Circadian Rhythm Sleep Disorder, Unspecified" (1 trials). Many other conditions were trialed in "Yale New Haven Hospital, York Street Campus" in a lesser frequency.

Most popular intervention types in "Yale New Haven Hospital, York Street Campus" are "Device" (2 trials), "Dietary Supplement" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "10,000 lux bright light, 4 hours" (1 trials), "10,000 lux bright light, 8 hours" (1 trials), "Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate" (1 trials), "Bupivacaine-Liposomal Bupivacaine" (1 trials) and "Continuous feeds participant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale New Haven Hospital, York Street Campus" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yale New Haven Hospital, York Street Campus". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Yale New Haven Hospital, York Street Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale New Haven Hospital, York Street Campus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".